Filter
630
Text search:
JJ
Medicine
Featured
Recommendations
49
New Publications
89
Language
Document type
No document type
308
Studies & Reports
169
Guidelines
96
Manuals
31
Training Material
11
Fact sheets
7
Strategic & Response Plan
6
Videos
2
Countries / Regions
Global
33
India
20
Africa
19
Brazil
14
Latin America and the Carribbean
14
Russia
13
South Africa
11
Uganda
9
Ethiopia
8
Kenya
8
Malawi
8
Ukraine
7
Sierra Leone
6
Zimbabwe
6
Mozambique
6
Cameroon
5
Philippines
5
Germany
5
Tanzania
5
Western and Central Europe
5
Congo, Democratic Republic of
4
USA
4
Zambia
4
Indonesia
4
Peru
4
Eastern Europe
4
Burkina Faso
3
Haiti
3
Rwanda
3
Bangladesh
3
Colombia
3
Angola
3
Paraguay
3
Asia
3
North America
3
Spain
3
Liberia
2
Nigeria
2
Guinea-Bissau
2
Nepal
2
Afghanistan
2
West and Central Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Venezuela
2
Guinea
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Ghana
1
Pakistan
1
South Sudan
1
Syria
1
Thailand
1
Singapore
1
Papua New Guinea
1
Sudan
1
Benin
1
Argentina
1
Eswatini/ Swaziland
1
Burundi
1
Ecuador
1
Botswana
1
El Salvador
1
Bolivia
1
Madagascar
1
Lesotho
1
Myanmar / Burma
1
Sri Lanka
1
Chile
1
East and Southern Africa
1
South–East Asia Region
1
Mongolia
1
Qatar
1
Moldova
1
Kyrgyzstan
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
153
Clinical Guidelines
63
Public Health
37
Women & Child Health
27
Capacity Building
7
Key Resources
3
Pharmacy & Technologies
1
Toolboxes
Mental Health
104
COVID-19
68
HIV
55
NTDs
43
TB
42
NCDs
39
Planetary Health
32
Ebola & Marburg
26
AMR
20
Disability
15
Caregiver
10
Pharmacy
10
Global Health Education
9
Zika
7
Malaria
6
Rapid Response
3
Social Ethics
3
Cholera
2
Refugee
2
Polio
1
Natural Hazards
1
Specific Hazards
1
Health Financing Toolbox
1
2.0 Rapid Response
1
Research Article
Karo et al. BMC Infectious Diseases 2014, 14:148 http://www.biomedcentral.com/1471-2334/14/148
orientations provisoires, 14 juin 2021
Consideraciones para aplicar y ajustar medidas de salud pública y sociales en el contexto de la COVID-19
recommended
orientaciones provisionales, 14 de junio de 2021
This is the sixth of our 11-paper supplement entitled “Community Health Workers at the Dawn of New Era”. Expectations of community health workers (CHWs) have expanded in recent years to encompass a wider array
of services to numerous subpopulations, engage communities to collaborate with and to
...
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the
...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog
...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform
...
Rapport sur les populations clès
Accessed November 2017
Considerations on the implementation and adjustment of
public health and social measures in the context of
COVID-19
Interim guidance 14 June 2021
A series of information sheets to help empower communities and strengthen health systems
This series of information sheets introduces health literacy, its
relevance to public policy, and the ways it can be used to inform
the promotion of good health, the prevention and management
of communicab
...
Esta guía está enfocada en emitir recomendaciones para el diagnóstico y el tratamiento de la enfermedad de Chagas, como infección por Trypanosoma cruzi, agente protozoario de una parasitosis sistémica. Metodología: La presente guía de práctica clínica fue confeccionada siguiendo los método
...
BMC Res Notes (2016) 9:182 DOI 10.1186/s13104-016-1993-7
The Faster We Go, the Health We'll Be.
The report outlines five climate solutions that research shows will deliver immediate, often localized, health and equity benefits. Our focus is on the solutions that proactively advance both health and health equity, recognizing that some of us face greater h
...
Curr Opin Pharmacol . 2022 Apr;63:102203.doi: 10.1016/j.coph.2022.102203. Epub 2022 Feb 11.
The COVID-19 pandemic has widespread economic and social effects on Latin America (LA) and the Caribbean (CA). This region, which has a high prevalence of chronic diseases, has been one of the most affected
...
Desde hace muchas décadas, los microbios, en particular las bacterias, se han vuelto cada vez más resistentes a diversos antimicrobianos. El aval de la Asamblea Mundial de la Salud al Plan de Acción Mundial sobre la resistencia a los antimicrobianos, en mayo de 2015, y la Declaración política d
...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t
...
The Fifty-first World Health Assembly adopted resolution WHA51.11 in 1998, which targets the
global elimination of trachoma as a public health problem by 2020 (1). The strategy recommended
to achieve that goal is encapsulated by the acronym “SAFE”, which represents: Surgery for
individuals wi
...
This document updates the 2014 Core Elements for Hospital Antibiotic Stewardship Programs and incorporates new evidence and lessons learned from experience with the Core Elements. The Core Elements are applicable in all hospitals, regardless of size. There are suggestions specific to small and criti
...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID
...
